Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.23.3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue $ 7,319,000 $ 7,007,000 $ 60,050,000 $ 16,120,000
Operating expenses        
Research and development (37,788,000) (33,182,000) (93,301,000) (104,674,000)
General and administrative (16,164,000) (16,815,000) (56,634,000) (48,169,000)
Total operating expenses (53,952,000) (49,997,000) (149,935,000) (152,843,000)
Operating loss (46,633,000) (42,990,000) (89,885,000) (136,723,000)
Interest income 2,149,000 324,000 4,368,000 1,019,000
Gain on bargain purchase     22,049,000  
Remeasurement on bargain purchase (106,000)      
Other income (expense), net (324,000) 1,644,000 (494,000) 1,001,000
Loss before income tax expense (44,914,000) (41,022,000) (63,962,000) (134,703,000)
Income tax expense (687,000) (399,000) (1,992,000) (1,503,000)
Net loss attributable to ordinary shareholders $ (45,601,000) $ (41,421,000) $ (65,954,000) $ (136,206,000)
Net loss per ordinary share        
Basic (in dollars per share) $ (0.03) $ (0.04) $ (0.06) $ (0.14)
Diluted (in dollars per share) $ (0.03) $ (0.04) $ (0.06) $ (0.14)
Weighted average shares outstanding:        
Basic (in shares) 1,357,849,656 980,791,114 1,153,791,567 961,354,122
Diluted (in shares) 1,357,849,656 980,791,114 1,153,791,567 961,354,122